Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Applied Radiation and Isotopes

• Publication date

  2011-12-01

• Fields of study

  Medicine, Physics, Environmental Science

• Identifiers
  DOI 10.1016/j.apradiso.2011.02.030PMID 21570311
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Boron neutron capture therapy for glioblastoma.

  2008cited by this paper
• Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.

  2007cited by this paper
• First clinical case of boron neutron capture therapy for head and neck malignancies using 18F‐BPA PET

  2006cited by this paper
• Anaplastic Thyroid Carcinoma: Biology, Pathogenesis, Prognostic Factors, and Treatment Approaches

  2006cited by this paper
• BORON NEUTRON CAPTURE THERAPY FOR RECURRENT HEAD AND NECK MALIGNANCIES

  2005cited by this paper
• Application of boron neutron capture therapy to the treatment of anaplastic thyroid carcinoma: current status and future perspectives

  2005cited by this paper
• Biodistribution studies of boronophenylalanine-fructose in melanoma and brain tumor patients in Argentina.

  2004cited by this paper
• Effectiveness of BNCT for recurrent head and neck malignancies.

  2004cited by this paper
• Experimental application of boron neutron capture therapy to undifferentiated thyroid carcinoma.

  2003cited by this paper
• Selective Uptake of p-Borophenylalanine by Undifferentiated Thyroid Carcinoma for Boron Neutron Capture Therapy

  2002cited by this paper
• Mechanisms of Transport of p-Borono-Phenylalanine through the Cell Membrane In Vitro

  2000cited by this paper
• The radiation biology of boron neutron capture therapy.

  1999cited by this paper
• Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

  1998cited by this paper
• Prognostic factors for thyroid carcinoma

  1997cited by this paper
• In vivo diagnosis of human malignant melanoma with positron emission tomography using specific melanoma-seeking 18F-DOPA analogue

  1997cited by this paper
• Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131I-radiolabeled murine monoclonal antibody in a human glioma xenograft model.

  1988cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Role of the TGF-β/SMAD pathway in tumor radioresistance to boron neutron capture therapy (BNCT) in a human cell line of colon adenocarcinoma.

  2025cites this paper
• ‘Cell knife’ for cancer: the clinician’s perspective

  2025cites this paper
• Effect of Neutron Radiation on 10BPA-Loaded Melanoma Spheroids and Melanocytes

  2025influential citation
• Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT)

  2022cites this paper
• Boron neutron capture therapy as salvage treatment for recurrent papillary thyroid carcinoma—a case report

  2020cites this paper
• Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

  2020cites this paper
• Bimodal Therapeutic Agents against Glioblastoma, one of the most Lethal Cancer.

  2020cites this paper
• Urinary Proteomics Profiles Are Useful for Detection of Cancer Biomarkers and Changes Induced by Therapeutic Procedures

  2019cites this paper
• In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line

  2018cites this paper
• Blood-brain barrier (BBB) toxicity and permeability assessment after L-(4-¹⁰Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model.

  2014cites this paper
• Short and long-term exposure of CNS cell lines to BPA-f a radiosensitizer for boron neutron capture therapy: safety dose evaluation by a battery of cytotoxicity tests.

  2013cites this paper
• Studies on the Possible Application of BNCT to Thyroid Cancer

  2012cites this paper